What happened
B. Braun Medical Inc. voluntarily recalled three lots of 0.9% Sodium Chloride Injection USP, 100 mL in 150 mL PAB® containers, nationwide at the hospital, healthcare facility, and user levels. The recall followed detection of particulate matter identified as zinc oxide. Affected lots are J6B435, J6B444, and J6B457, with expiration date 30APR2027; distribution occurred from February 27, 2026 through August 3, 2026. The company warned that intravenous administration could cause life-threatening vascular, immune, organ, or blood-cell effects. No serious injuries, deaths, or other adverse events had been reported. B. Braun is notifying distributors and customers and arranging returns and replacements.
Why it matters
From a GMP/manufacturing perspective, the reported zinc oxide particulate matter may warrant attention to contamination control and controls intended to prevent foreign particles in an injectable product. The nationwide recall of three lots also highlights the importance of lot traceability, distribution records, and recall execution. The source does not identify the particulate source, manufacturing root cause, or corrective and preventive actions, so no conclusion on those points is supported.
Key topics: Zinc oxide particulate matter in sodium chloride injection, Nationwide recall of three injectable product lots, Return and replacement of affected PAB containers